China Medical (International) Group Limited together with its subsidiary corporations (the “Group”) started its distribution and agency business in 1987, supplying quality products and related solutions for the metal industries in ASEAN.
The Group represent international producers in the distribution of a range of raw materials, consumables and disposable supplies, measuring systems, equipment and engineering spares for steel melting plants, steel rolling mills, cast iron and steel foundries.
In November 2015, the Group diversified into the aesthetics medical and healthcare sector with the acquisition of a majority stake in China iMyth Company Pte. Ltd. (“China iMyth”) which holds an aesthetics medical practice in Taipei. China iMyth focuses on aesthetics medicine including botox, laser treatments, plastic surgery, anti-ageing treatments and detoxification. China iMyth also intends to expand into People’s Republic of China by partnering and collaborating with aesthetics clinics in Shenzhen and eventually to other cities.
China Medical’s other interest in People’s Republic of China includes a kidney hospital and an aesthetics medical clinic in Qingdao, a city in the eastern Shandong province.
|Full Name||China Medical (International) Group Limited||Stock No||5IB|
|Exchange||Singapore Exchange (SGX)||Board||Catalist|
|Par Value (SGD)||0.0000||Issued Shares (Mil)||2999.1330|
|Paid-Up Cap. (SGD Mil)||50.0000||Market Capitalization (Mil)||2.9991|
|Share Price (SGD)|
|Share Price Performance(%)|
|100-day Average Daily Volume ('000)||14,026.76|
|Technical Indicators-A shapshot|